Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
05/2006
05/02/2006US7037880 Ethylene derivatives and pesticides containing said derivatives
05/02/2006CA2250426C Amidinohydrazones as protease inhibitors
04/2006
04/27/2006WO2006044528A1 Pyrazole derivatives as phosphodiesterase 4 inhibitors
04/27/2006WO2006044379A2 Novel curcumin analogues and uses thereof
04/27/2006WO2006042600A1 Agent and method for identifying furfurals
04/27/2006WO2006025069A3 Tricyclic pyrazole derivatives as cannabinoid receptor modulators
04/27/2006WO2006014290A3 Anti-inflammatory medicaments
04/27/2006US20060089399 Pyrazolyl carboxanilides for controlling unwanted microorganisms
04/27/2006US20060089393 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
04/27/2006US20060089375 Pyrazolo[3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors
04/27/2006US20060089371 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist
04/27/2006CA2584317A1 Pyrazole derivatives as phosphodiesterase 4 inhibitors
04/27/2006CA2583943A1 Novel curcumin analogues and uses thereof
04/26/2006EP1650194A1 Protein kinase inhibitor
04/26/2006EP1648867A1 Ppar active compounds
04/26/2006EP1648448A1 Chemical compounds
04/26/2006EP1309592B1 Substituted pyrazoles
04/26/2006CN1764658A Preparation and use of 2-substituted-5-oxo-3- pyrazolidinecarboxylates
04/26/2006CN1764623A Process for producing tetraalkoxypropane and derivative thereof
04/26/2006CN1764454A Cyclic protein tyrosine kinase inhibitors
04/26/2006CN1762989A Semicarbazone synthesis method
04/25/2006US7034154 Reacting a pyrazole with an enaminone to yield a halopyrazol-opyrimidine which is reacted with 2-thiophenecarboxylic acid chloride in the presence of zinc or magnesium or 2-thiophene boronic acid in the presence of carbon monoxide
04/25/2006US7034049 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
04/25/2006US7034035 Having a high residual activity, greater activity at lower application rates, curative activity, and a broader spectrum of efficacy; heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality
04/25/2006US7034029 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
04/20/2006WO2006040529A1 Benzamide derivatives that act upon the glucokinase enzyme
04/20/2006WO2006040528A1 Phenoxy benzamide compounds with utility in the treatment of type 2 diabetes and obesity
04/20/2006WO2006040527A1 Process for making phenoxy benzamide compounds
04/20/2006WO2006040351A1 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents
04/20/2006WO2006040136A1 Substituted 4-benzyloxy-phenylmethylamide derivatives as cold menthol receptor-1 (cmr-1) antagonists for the treatment of urological disorder
04/20/2006WO2006039977A1 3-(2-hydroxyphenyl) pyrazoles and their use as hsp90 modulators
04/20/2006US20060084681 Substituted pyrazoles, compositions containing such compounds and methods of use
04/20/2006US20060084680 ((1S)-5-{2-[(3-methyl-7-propyl-1,2-benzisoxazol-6-yl)oxy]ethoxy}-2,3-dihydro-1H-inden-1-yl)acetic acid; diabetes, obesity, hyperlipidemia, and atherosclerotic diseases; hyperglycemia, hyperinsulinemia, impaired glucose tolerance, dyslipidemia, hypertriglyceridemia, and insulin resistance
04/20/2006US20060084657 Piperazine derivative
04/20/2006CA2583292A1 3-(2-hydroxyphenyl) pyrazoles and their use as hsp90 modulators
04/20/2006CA2583015A1 Substituted 4-benzyloxy-phenylmethylamide derivatives as cold menthol receptor-1 (cmr-1) antagonists for the treatment of urological disorder
04/20/2006CA2582180A1 Indazoles, benzisoxazoles and benzisothiazoles, process for preparing them, pharmaceutical compositions and use as estrogenic agents
04/20/2006CA2581619A1 Process for making phenoxy benzamide compounds
04/19/2006EP1647549A1 Indazoles, benzisoxazoles and benzisothiazoles as estrogenic agents
04/19/2006EP1646616A2 Combretastatin derivatives with cytotoxic action
04/19/2006EP1646382A2 Compounds, compositions and methods
04/19/2006EP1534711B1 Phenyl-substituted pyrazolopyrimidines
04/19/2006EP1463730B1 Pyrazolopyridazine derivatives
04/19/2006EP1420784B1 Compounds effecting glucokinase
04/19/2006CN1761654A Pyrazole compound
04/19/2006CN1761649A Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase A2
04/19/2006CN1252055C Biphenyl carboxamides compounds
04/18/2006US7030238 C-nitroso compounds and use thereof
04/18/2006US7030141 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
04/18/2006US7029835 Photothermographic element comprising improved base precursors and methods for their use
04/13/2006WO2006038685A1 Filter for electronic display
04/13/2006WO2006037982A2 Modulators of crth2 receptor activity for the treatment of prostaglandin d2 mediated diseases
04/13/2006WO2006037496A1 Polyhalogenated propene benzoquinone dioxime derivatives and its use as pesticides
04/13/2006WO2005116027A3 Indazole and indolone derivatives and their use as pharmaceuticals
04/13/2006WO2005007621A3 Ubiquitin ligase inhibitors
04/13/2006US20060079566 Phosphoinositide-dependent kinase-1 (PDK-1) inhibitors; for the treatment and prevention of cancer in humans; 4-[5-(2-Phenanthracenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenecarboxamide
04/13/2006US20060079563 Cyclic protein tyrosine kinase inhibitors
04/13/2006US20060079561 Insecticidal anthranilamides
04/13/2006US20060079549 Administering a stimulantfor the endogenous production/ release of somatotropins; 3-((1-(2-aminoprop-2-yl)carbonylamino-),2-(phenylmethoxymethyl-)ethyl-),5-(morpholino-carbonyloxymethyl-)-5,6,7,8-tetrahydro-1,2,4-triazolo(4,3-)pyridine; osteoporosis; obesity;improving bone densisty, muscle mass/strength
04/13/2006DE102004049078A1 Phenylpyrazole Phenylpyrazoles
04/13/2006DE102004023635A1 Heteroarylsubstituierte Cyclohexyl-1,4-diamin-Derivate Heteroaryl-cyclohexyl-1,4-diamine derivatives
04/12/2006EP1645556A1 Arylpiperazine-benzoylamide derivatives useful as pharmaceutical agents
04/12/2006EP1644326A1 Cathepsin cysteine protease inhibitors
04/12/2006EP1644320A1 Indane derivates as muscarinic receptor agonists
04/12/2006EP1644314A1 Method for producing difluoro-acetyl-acetic acid alkylesters
04/12/2006EP1644050A1 Bifunctional tridentate pyrazolyl containing ligands for re, tc and mn tricarbonyl complexes
04/12/2006EP1643992A2 New n-hydroxy-4-(3-phenyl-5-methyl-isoxazole-4-yl)-benzenesulfonamide solvates
04/12/2006EP1643960A2 Arylsulfonamide derivatives
04/12/2006EP1495015B1 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers
04/12/2006EP1003736B1 Substituted 4-benzoyl-pyrazoles
04/12/2006EP0843549B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor
04/12/2006CN1759105A Insecticidal phthalamide derivatives
04/12/2006CN1759102A Monoazo iron complex compound, charge control agent containing the same, and toner
04/12/2006CN1250539C Intermediate for preparing 1-[halogenarylradical] heterocyclic pesticide compound
04/12/2006CN1250223C Pyrrolo-triazine and pyrimidine compounds
04/12/2006CN1250220C Use of central cannabinoid receptor antagonist for preparing medicines designed to facilitate smoking cessation
04/11/2006US7026476 Intermediate arylamine compounds
04/11/2006US7026348 Antiinflammatory agents; sepsis shock; rheumatic diseases
04/11/2006US7026346 Anticancer agents
04/11/2006US7026339 Inhibitors of HCV NS5B polymerase
04/06/2006WO2006036498A2 A process for the preparation of 1,3,5-trisubstituted pyrazoles via [3+2] cycloaddition
04/06/2006WO2006034804A1 Indozolone derivatives as 11b-hsd1 inhibitors
04/06/2006US20060074245 Reacting a 5-( beta -ketoalkyl)-3-substituted-1,2,4-oxadiazoles compound with hydrazine
04/06/2006US20060074122 e.g., N-butyl-6-chloro-5-phenyl-1H-indazol-3-amine; kinase inhibitor; obesity and stroke; diseases involving phosphorylation of the tau protein such as Alzheimer's disease, Parkinson's disease, frontoparietal dementia
04/06/2006US20060074120 cyclopent[f]pyrazole derivatives; antiinflammatory agent; autoimmune diseases; side effect reduction, advantages over steroidal glucocorticoid ligands with respect to undesireable side-effects, efficacy, toxicity or metabolism
04/06/2006CA2581747A1 Process for preparing bicyclic pyrazolyl compounds
04/05/2006EP1641764A1 5-membered heterocycle-based p38 kinase inhibitors
04/05/2006EP1641763A2 4-cyanopyrazole-3-carboxamide derivatives preparation and therapeutic application thereof
04/05/2006EP1641762A2 Cck-1 receptor modulators
04/05/2006EP1641465A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid
04/05/2006EP1641452A1 Heterocyclic compounds useful to treat hcv
04/05/2006EP1331005B1 Medicinal compositions for concominant use as anticancer atent
04/05/2006EP1173427B1 Hydroxamic acid derivative
04/05/2006CN1756747A Anti-inflammatory medicaments
04/05/2006CN1249064C Tosylate and benzene sulfonate of pyrazolopy ridone compound
04/05/2006CN1249052C Pyrazole derivatives as HIV reverse transcriptase inhibitors
04/04/2006US7022845 Monomethylation of nitrogeneous heterocycles
04/04/2006CA2294624C Cationic monobenzene nitrophenylenediamines, their use in dying keratin fibres, dyeing compositions containing them and dyeing processes
03/2006
03/30/2006WO2005120515A3 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
03/30/2006US20060069270 Process for the preparation of 1,3,5-trisubstituted pyrazoles via [3+2] cycloaddition